Login / Signup

Association between smoking and all-cause mortality in Parkinson's disease.

Seo Yeon YoonYou Hyun ParkSang Chul LeeJee Hyun SuhSeung Nam YangDae Ryong KangYong Wook Kim
Published in: NPJ Parkinson's disease (2023)
We aimed to investigate the association between smoking status and all-cause mortality of Parkinson's disease (PD). Among the whole nationwide population data from Korea National Health Insurance Service, newly diagnosed PD was selected, and all-cause mortality was evaluated. The systematic review was performed through a literature search on the PubMed, EMBASE, and Cochrane Central Register of Controlled Trials databases. Among 26,080 individuals with PD, there was no significant association between smoking status and all-cause mortality in a nationwide cohort study (ex-smoker, HR 0.1.03, 95% CI 0.97-1.10; current smoker, HR 1.06, 95% CI 0.96-1.16). The systematic review, including six prospective cohort studies, also found a nonsignificant association. PD smokers tended to have fewer deaths from neurologic causes but were significantly more likely to die from smoking-related cancers such as lung cancer. We presented a nonsignificant association between smoking and mortality of PD, and cigarette smoking is not recommended in individuals with PD.
Keyphrases
  • systematic review
  • smoking cessation
  • health insurance
  • newly diagnosed
  • healthcare
  • meta analyses
  • mental health
  • big data
  • cardiovascular events
  • risk factors
  • randomized controlled trial
  • cross sectional
  • machine learning